Medicine Description adcetris 50mg
Adcetris is a vial formulation used for intravenous infusion preparation. It contains the active substance brentuximab
vedotin and is classified as an anticancer medication used in the treatment of certain types of lymphomas.
The drug works by precisely targeting cancer cells, helping to reduce their growth and spread within the body. It is
used in specific medical conditions under the supervision of a specialized oncology team and is typically dispensed
only in hospitals or specialized treatment centers.
Adcetris Ingredients
Adcetris contains the following active ingredient:
Adcetris Strengths
This medication is available as a vial containing a 50 mg concentrated powder. It is reconstituted into a solution for
intravenous infusion only under medical supervision in a hospital setting. It is not available in oral form and should
not be used by any other route of administration.
Uses of Adcetris
The main uses of Adcetris include:
Treatment of Hodgkin lymphoma
Treatment of systemic anaplastic large cell lymphoma
Treatment of certain types of T-cell lymphomas
Use in advanced or relapsed cases
Part of specialized oncology treatment protocols
Adcetris Dosage
The dose is determined individually based on the patient’s body weight and medical condition. It is administered
exclusively as an intravenous infusion in a hospital under the supervision of a specialist.
Treatment is usually repeated at scheduled intervals, often every 3 weeks, according to the treatment plan. Dosage or
timing may be adjusted based on the patient’s response or the occurrence of side effects.
Side Effects of Adcetris
Common side effects may include:
Contraindications of Adcetris
Adcetris should not be used in patients with severe hypersensitivity to the active substance or any of its components.
It is also contraindicated in patients with uncontrolled active infections or severe bone marrow suppression unless
carefully evaluated by a physician.
Caution is required in patients with liver or kidney impairment or significant neuropathy. Its suitability must always
be determined by a specialist oncologist.
How to Use Adcetris Properly
The medication should be used strictly according to medical instructions:
Administered only in a hospital via intravenous infusion
Prepared by trained pharmacy specialists
Not for home use
Patient monitoring is required during and after infusion
Strict adherence to scheduled dosing intervals
Use During Pregnancy and Breastfeeding
Adcetris should be avoided during pregnancy unless absolutely necessary and only under strict medical supervision.
Effective contraception must be used during treatment.
It is not recommended during breastfeeding. Patients should consult their physician before planning pregnancy, as a
careful risk-benefit assessment is required to ensure safe use.
Storage Conditions
Adcetris should be stored under the following conditions:
Store at an appropriate temperature as specified in the product leaflet
Protect from direct light
Keep out of reach of children
Do not freeze
Keep in the original packaging until use